Skip to content

Released May 10, 2022, after the close

10-Q filed May 10, 2022, 40 days after period end · 0001636422-22-000024

Q1 2022 · 10-Q
Revenue$68.09M+21.9% vs Q1 2021+5.2% vs Q4 2021
Net Income-$22.46MN/M vs Q1 2021N/M vs Q4 2021
EPS Diluted-$0.54N/M vs Q1 2021no prior Q4 2021 on file
Operating Income-$24,347,000N/M
Operating Cash Flow$1,158,000N/M
Free Cash Flowderived$802,000N/M
Margins · derived
Operating margin-35.8%+7.8 pt vs Q1 2021
Net margin-33.0%+17.8 pt vs Q1 2021

What the release said

The release

Same quarter

MetricQ1 2022Q1 2021Q1 2020Q1 2019
Revenue$68.09M$55.85M$45.12M$35.21M
Net Income-$22.46M-$28.37M-$17.49M-$13.72M
EPS Diluted-$0.54-$0.65-$0.47-$16.21

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR